Evidence map›Paper›PMID 26643057›Full record

ReviewMicrobiology (Reading, England)2016

Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.

Jean Tyrrell, Máire Callaghan

Abstract readReview
In one paragraph

Review in Microbiology (Reading, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Exploring the Biocontrol Potential ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Impact ofInternational journal of molecular sciences · 2022
    Review
  11. Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.International journal of molecular sciences · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Ferrous Iron-Dependent Pharmacology.Trends in pharmacological sciences · 2021
    Review
  19. Iron at the host-microbe interface.Molecular aspects of medicine · 2020
    Review
  20. Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jean TyrrellCentre of Microbial Host Interactions, Institute of Technology Tallaght, Dublin D24KT9, Ireland.
Máire CallaghanCentre of Microbial Host Interactions, Institute of Technology Tallaght, Dublin D24KT9, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron acquisition is vital to microbial survival and is implicated in the virulence of many of the pathogens that reside in the cystic fibrosis (CF) lung. The multifaceted nature of iron acquisition by both bacterial and fungal pathogens encompasses a range of conserved and species-specific mechanisms, including secretion of iron-binding siderophores, utilization of siderophores from other species, release of iron from host iron-binding proteins and haemoproteins, and ferrous iron uptake. Pathogens adapt and deploy specific systems depending on iron availability, bioavailability of the iron pool, stage of infection and presence of competing pathogens. Understanding the dynamics of pathogen iron acquisition has the potential to unveil new avenues for therapeutic intervention to treat both acute and chronic CF infections. Here, we examine the range of strategies utilized by the primary CF pathogens to acquire iron and discuss the different approaches to targeting iron acquisition systems as an antimicrobial strategy.

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorHumansIronIron-Binding ProteinsLungMicrobiotaMucociliary ClearancePseudomonas aeruginosaPseudomonas InfectionsSiderophoresStaphylococcal InfectionsStaphylococcus aureusCFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorIronIron-Binding ProteinsSiderophores

Identifiers

PMID26643057
PMCPMC4772740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.